01
02
03
The limited biocompatibility of vascular implants reduces their long-term performance and their scope of application.
The innermost surface of native blood vessels is covered by a single layer of endothelial cells, providing a unique antithrombogenic barrier.
Vascuzell's technology enables the direct incorporation of vascular cells to improve implant acceptance.
Latest News